Jia Jie Biomedical Co., Ltd. engages in the soft-shelled turtle food processing, manufacturing, sales, and trading business.
Share Price & News
How has Jia Jie Biomedical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4109 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 4109's weekly volatility (3%) has been stable over the past year.
7 Day Return
TW Personal Products
1 Year Return
TW Personal Products
Return vs Industry: 4109 exceeded the TW Personal Products industry which returned -17% over the past year.
Return vs Market: 4109 underperformed the TW Market which returned 33.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Jia Jie Biomedical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Jia Jie Biomedical Fundamentals Summary
|4109 fundamental statistics|
Is 4109 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4109 income statement (TTM)|
|Cost of Revenue||NT$169.75m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.10|
|Net Profit Margin||-3.49%|
How did 4109 perform over the long term?See historical performance and comparison
Is Jia Jie Biomedical undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 4109's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 4109's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 4109 is unprofitable, so we can't compare its PE Ratio to the TW Personal Products industry average.
PE vs Market: 4109 is unprofitable, so we can't compare its PE Ratio to the TW market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 4109's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 4109 is good value based on its PB Ratio (1.3x) compared to the TW Personal Products industry average (2x).
How is Jia Jie Biomedical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jia Jie Biomedical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Jia Jie Biomedical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4109 is currently unprofitable.
Growing Profit Margin: 4109 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 4109 is unprofitable, but has reduced losses over the past 5 years at a rate of 6.1% per year.
Accelerating Growth: Unable to compare 4109's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4109 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (17.9%).
Return on Equity
High ROE: 4109 has a negative Return on Equity (-0.94%), as it is currently unprofitable.
How is Jia Jie Biomedical's financial position?
Financial Position Analysis
Short Term Liabilities: 4109's short term assets (NT$360.3M) exceed its short term liabilities (NT$61.4M).
Long Term Liabilities: 4109's short term assets (NT$360.3M) exceed its long term liabilities (NT$2.1M).
Debt to Equity History and Analysis
Debt Level: 4109 is debt free.
Reducing Debt: 4109 has no debt compared to 5 years ago when its debt to equity ratio was 47.5%.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 4109 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 4109 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 59.7% per year.
What is Jia Jie Biomedical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 4109's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 4109's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 4109's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 4109's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 4109 is not paying a notable dividend for the TW market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 4109's dividend in 3 years as they are not forecast to pay a notable one for the TW market.
How experienced are the management team and are they aligned to shareholders interests?
Jia Jie Biomedical has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29%.
Jia Jie Biomedical Co., Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Jia Jie Biomedical Co., Ltd.
- Ticker: 4109
- Exchange: TPEX
- Founded: 1995
- Industry: Personal Products
- Sector: Household
- Market Cap: NT$1.174b
- Shares outstanding: 88.94m
- Website: https://www.jiajiebio.com
- Jia Jie Biomedical Co., Ltd.
- No. 61, Jiuru 1st Road
- 3rd Floor
Jia Jie Biomedical Co., Ltd. engages in the soft-shelled turtle food processing, manufacturing, sales, and trading business. It is also involved in the dairy products manufacturing, miscellaneous food manu...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/18 08:32|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.